A New Rationalization For A Slow Sunday: #57A The Utilitarian Cheat, or “If It Saves Just One Life”

On another thread, a reader attacked the Rationalization List <GASP!>,, the beating heart of Ethics Alarms, arguing that many of what are labelled rationalizations are valid justifications and cited as such on this very site. A vile canard! Of course many rationalizations can also be valid arguments for or against conduct. Take #59. The Ironic Rationalization, or “It’s The Right Thing To Do.” We do the right things because they are right, but we also have calculated why they are right, which means dealing with and rebutting the counter-arguments that might suggest those decisions are not right.  However, #59 addresses the frequent use of the “It’s the right thing to do” as a argument-ender, employing it as evidence when it really has to be a conclusion based on other evidence and analysis.

The latest addition to the Ethics Alarms Rationalization List does not have this problem. It is almost always a cheap rhetorical device, slyly edging what needs to be a clear-eyed, rational analysis of proposed conduct into the confounding realm of emotion. #57 A, The Utilitarian Cheat or “If its saves just one life” is a sub-rationalization under #57, 57. The Universal Trump, or “Think of the children!”  (It could easily be the other way around.)

#57 A. The Utilitarian Cheat or “If it saves just one life”

Invoking Rationalization #57A is as good a test as there is for identifying an untrustworthy demagogue. The claim that something is worth enacting, eliminating, establishing or doing is ethically and morally validates “if it saves juts one life” is aimed directly at the mushy minds of sentimentalists  and the dangerously compassionate. If the argument is made in good faith, the speaker is an incompetent dolt; usually it is the desperate last resort of a someone who has found that their real arguments are inadequate or unpersuasive.

The insidious trick inherent in the device is that we agree that human life is precious, and that we can not and will not place a dollar sign on a human being. The next step, however, in which a single life, or even many, is deemed justification for any expense or other draconian societal trade-offs, is impractical and irrational. It would save many lives if automobiles were built like tanks and could never exceed five miles an hour. Locking up ever angry husband that threatened the life of an estranged spouse with a menacing phone call would save many lives. So would forcing women to carry their babies to term, eliminating the right to have an abortion. Torture used without restrictions probably would save one life or more. Prohibition was sold using #57A.

All of these policy conundrums and many others are too complex by far to use simple-minded absolutism as their ethical guideline, and about 30 seconds of logical clarity will usually make that clear.  Those who employ The Utilitarian Cheat, however, don’t want clarity. It is an appeal to embrace acts that can do wide-ranging harm to society, civilization, human aspirations and liberty, because un-named lives can be saved. Though it is opposite of the exploitation of human life for other goals that Kantian ethics forbids, it is equally invalid.

___________________________

Graphic: gunssavelives.net

Unethical Quote of the Week: CNBC Financial Analyst Larry Kudlow

We've all been there, Larry. Still sounded awful, though.

The human toll here looks to be much worse than the economic toll, and we can be grateful for that.”

CNBC’s financial guru Larry Kudlow, discussing the economic implications of the Japanese earthquake and its aftermatha legitimate topic—while giving an instructive demonstration of how tunnel-vision and focus on one objective above all else can disable an ethics alarm, momentarily, or even permanently.

The quote speaks for itself, but here are a few comments: Continue reading

Ethics and the $1000 a Day Drug

Yesterday, The New York Times  informed us that a small drug company called Allos is charging $30,000 a month for a cancer drug, Folotyn, that treats a rare and usually fatal form of cancer that strikes fewer that 6,000 American a year. It doesn’t cure the cancer, but merely slows it down; even with that, victims seldom survive more than a few months. “This drug is not a home run. It’s not even a double. It’s a single,” the Times quotes Dr. Brad S. Kahl, a lymphoma specialist at the University of Wisconsin, as saying. Continue reading